Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication

NCT07115173 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Infection

Interventions

DRUG: This study aims to evaluate the efficacy and safety of a 14-day triple therapy regimen consisting of Zastaprazan 20 mg, clarithromycin, and amoxicillin for the eradication of Helicobacter pylori.

Sponsor

Samsung Medical Center